The Current Status of US and Global Access to Direct‐Acting Antiviral Regimens for Hepatitis C Virus Infection

Lignende værker

• Price and affordability of direct-acting antiviral regimens for hepatitis C virus in the United States
  af: Rosenthal, Elana S., et al.
  Udgivet: (2016)
• Current Status of Direct Acting Antiviral Agents against Hepatitis C Virus Infection in Pakistan
  af: Khaliq, Saba, et al.
  Udgivet: (2018)
• Roadblocks to Accessing Direct-Acting Antiviral Agents for Treatment of Hepatitis C Virus Infection
  af: Bernstein, David E.
  Udgivet: (2015)
• Hepatocellular Carcinoma Risk According to Regimens for Eradication of Hepatitis C Virus; Interferon or Direct Acting Antivirals
  af: Lee, Hye Won, et al.
  Udgivet: (2020)
• Direct-acting Antiviral Regimens for Patients with Chronic Infection of Hepatitis C Virus Genotype 3 in China
  af: Wang, Xiaozhong, et al.
  Udgivet: (2021)